Application 125274
- Type
- BLA
- Sponsor
- IPSEN BIOPHARM LTD
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125274 | Dysport | abobotulinumtoxinA | 351(a) | Rx | 2026-06-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DYSPORT | abobotulinumtoxinA | INJECTABLE; INJECTION | 500 UNITS/VIAL | No | No |
| 002 | DYSPORT | abobotulinumtoxinA | INJECTABLE; INJECTION | 300 UNITS/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dysport | BOTULINUM TOXIN TYPE A | Galderma Laboratories, L.P. | 71313a04-1349-4c26-b840-a39e4a3ddaed | 2024-10-24 | Boxed warning, Warnings, Adverse reactions | BLA125274 0299-5962 |
| Dysport | BOTULINUM TOXIN TYPE A | Ipsen Biopharmaceuticals, Inc. | 97513722-8426-4ce3-b85d-0e08e436a140 | 2023-09-28 | Boxed warning, Warnings, Adverse reactions | BLA125274 15054-0500 15054-0530 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0299-5962 | Dysport | Botulinum Toxin Type A | Galderma Laboratories, L.P. | BLA | Current |
| 0299-5962 | Dysport | Botulinum Toxin Type A | Galderma Laboratories, L.P. | BLA | Current |
| 0299-5962 | Dysport | Botulinum Toxin Type A | Galderma Laboratories, L.P. | BLA | Current |
| 0299-5962 | Dysport | Botulinum Toxin Type A | Galderma Laboratories, L.P. | BLA | Current |
| 0299-5962 | Dysport | Botulinum Toxin Type A | Galderma Laboratories, L.P. | BLA | Current |
| 15054-0500 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0500 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0500 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0500 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0530 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0530 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0530 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
| 15054-0530 | Dysport | Botulinum Toxin Type A | Ipsen Biopharmaceuticals, Inc. | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 75544 | SUPPL | 2023-09-22 |
| 75543 | SUPPL | 2023-09-22 |
| 75534 | SUPPL | 2023-09-22 |
| 73150 | SUPPL | 2023-01-13 |
| 73149 | SUPPL | 2023-01-13 |
| 73148 | SUPPL | 2023-01-13 |
| 64946 | SUPPL | 2020-10-20 |
| 64938 | SUPPL | 2020-10-20 |
| 64936 | SUPPL | 2020-10-20 |
| 63947 | SUPPL | 2020-07-17 |
| 60124 | SUPPL | 2019-09-26 |
| 60123 | SUPPL | 2019-09-26 |
| 60114 | SUPPL | 2019-09-26 |
| 56466 | SUPPL | 2018-11-15 |
| 56317 | SUPPL | 2018-11-06 |
| 48771 | SUPPL | 2017-06-19 |
| 48718 | SUPPL | 2017-06-15 |
| 46130 | SUPPL | 2016-12-13 |
| 46127 | SUPPL | 2016-12-13 |
| 31884 | SUPPL | 2016-08-02 |
| 18834 | SUPPL | 2016-08-02 |
| 31883 | SUPPL | 2015-07-16 |
| 44428 | ORIG | 2013-04-05 |
| 39890 | SUPPL | 2012-05-23 |
| 9661 | SUPPL | 2012-05-23 |
| 44795 | ORIG | 2011-08-17 |
| 43313 | SUPPL | 2011-08-17 |
| 24359 | SUPPL | 2011-08-17 |
| 22794 | ORIG | 2011-08-17 |
| 39889 | ORIG | 2009-06-04 |
| 18832 | SUPPL | 2009-06-04 |
| 31882 | SUPPL | 2009-05-07 |
| 31881 | ORIG | 2009-05-07 |
| 62863 | SUPPL | 1900-01-01 |
| 62862 | SUPPL | 1900-01-01 |
| 51424 | SUPPL | 1900-01-01 |
| 51421 | SUPPL | 1900-01-01 |
| 51390 | SUPPL | 1900-01-01 |